ViiV Healthcare (United Kingdom)

ViiV Healthcare (United Kingdom)

ViiV Healthcare is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS. Its global headquarters is located in London. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ViiV Healthcare (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

76%


Total
Publications

441


Total Open
Publications

337


Total
Citations

12K


Open Access
Percentage

76%


Total
Publications

441


Total Open
Publications

337


Total
Citations

12K

Wikipedia

Website

download

Breakdown

24% 45% 7% 24%

Publisher Open

24%

Both

45%

Other Platform Open

7%

Closed

24%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055606570Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

56%OA Journal

OA Journal 56%

167

Hybrid 34%

102

No Guarantees 10%

31

Other Platform Open

Domain 88%

202

Institution 24%

55

Other Internet 7%

16

Public 2%

5

Preprint 1%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
203
DOI
Other Internet
15
DANS - Data Archiving and Networked Services
Institution
11
University of Modena and Reggio Emilia - IRIS UNIMORE
Institution
10
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
8
Europe PMC
Domain
8
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
5
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
5
Figshare
Public
5
University of Nebraska Medical Center - DigitalCommons - UNMC
Institution
3
1 / 5

Data updated 18 August 2025

Share

Share

Share